Latest
industry research report on: Global Rabies Treatment Market :
Industry Size, Share, Research, Reviews, Analysis, Strategies,
Demand, Growth, Segmentation, Parameters, Forecasts
Global Rabies Treatment
Market: Snapshot
The global rabies treatment
market is anticipated to gain momentum in growth with three key
factors driving the demand in the industry. The application of novel
culture media to produce contamination-free vaccines and stringent
regulatory examinations conducted by governments could be first on
the list of important market drivers. There is a need to eliminate
the risk of vaccine contamination due to the involvement of human
components and bovine spongiform encephalopathy (BSE) agents in
cultural formulations. In this regard, manufacturers are focusing on
the development of novel media for vaccine production that are free
from human and animal components.
Complete Report Details @
https://www.marketresearchreports.biz/reports/1353555/rabies-treatment-global-industry-market-research-reports
The
emerging regions of the world are expected to be the major sources of
rabies on account of the lack of active rabies vaccination programs
and rising population of stray dogs. Exposure to rabid dogs is
studied to cause a 99.0% of rabies-related deaths and 90.0% of all
rabies cases, according to the Centers for Disease Control and
Prevention (CDC). As a result, the need for anti-rabies treatment
regimens such as rabies immunoglobulin (RIG) and cell culture vaccine
(CCV) for post-exposure prophylaxis is considerably high. This could
likely increase the demand in the global rabies treatment market.
However,
the expensive cost of CCV for intramuscular administration is
foretold to stunt its adoption and that of similar vaccines.
Nonetheless, in order to withstand this issue, WHO recommends the
intradermal administration of CCV, especially in regions where
intramuscular biological is unaffordable and unavailable and rabies
is extremely prevalent.
Rabies
is a zoonotic viral disease caused due to animal bits. The disease is
known to affect domestic as well as wild animals such as bats,
skunks, foxes, ferrets, raccoons, cats, or dogs, and infects humans
upon contact with saliva of infected animal. Rabies is known to have
an incubation period of one to three months. Individuals suffering
from rabies show initial symptoms of fever and pain or tingling or
burning sensation also called as paraesthesia at the wound site. As
the disease progresses through the central nervous system (CNS),
patients exhibit hyperactivity, excited behavior, hydrophobia. Rabies
can also be paralytic and accounts for approximately 3% of all rabies
cases globally according to World Health Organization (WHO). This
form is usually misdiagnosed and has slower progression. Muscles near
the wound site begin to paralyze; untreated infections lead to coma
and cause death.
WHO
statistics also show that although rabies is prevalent in all
continents except Antarctica, more than 95% of the mortalities occur
in African and Asian countries. Rabies infections are common in areas
where human-animal interaction is more and no proper medical
treatment facility is available for treatment. In the U.S. only 55
cases have been identified since 1955 according to Centers for
Disease Control and Prevention (CDC). Rapid diagnostic tests are
available for diagnosis of rabies. These tests are usually Enzyme
Linked Immunosorbent Assay (ELISA) or fluorescent assay technology.
Synbiotics Corporation, O.K. SERVIS BioPro, s.r.o., Bio-Rad
Laboratories, Inc. and Alpha Diagnostic International are some of the
players manufacturing diagnostic kits for rabies.
Have Any Query? Ask Our Expert @
https://www.marketresearchreports.biz/sample/enquiryBuy/1353555
Novartis and Sanofi are key
players in the global rabies treatment market. These companies
manufacture prophylactic vaccines for humans. Sanofi’s Imovax
Rabies is a human diploid cell vaccine; while Novartis’s RabAvert
is a Purified chick embryo cell vaccine. Vaccines are also available
for preventing infections in animals. Merial a Sanofi company
announced in July 2014 had it has launched PUREVAX Feline Rabies 3 YR
vaccine. This is a non-adjuvanted rabies vaccine and provides 3 year
immunity. The vaccine has been recommended for immunization of
healthy cats 12 weeks and older. Cadila Pharmaceuticals Ltd, is also
working on development of new generation rabies vaccine in India.
Under-developed countries have initiated mass vaccination of stray
dogs to control mortalities. According to an article published by
World Health Organization (WHO) in 2014, Kenya launched a nationwide
program for vaccination of dogs. Currently, more than 3,000 dogs in
Makueni County have been vaccinated. In September 2014, The
Philippines Department of Agriculture (DA), the Australian Government
and the World Organization for Animal Health (OIE) launched rabies
control project to reduce rabies cases due to dog in the Philippines.
Earlier in 2013, massive dog vaccination program was launched, which
vaccinated 92,869 dogs and attained 80% coverage according to a press
release by World Organization for Animal Health. An article published
in The Maravi Post, Malawi also plans to vaccinate 500,000 dogs and
cats to curb the rabies crisis. Such preventive programs will help in
reducing the prevalence of the disease in lower socio-economic
classes. With developing economic conditions and consistent
government initiatives, the prevalence of rabies is expected to
shrink in the future. Higher prevalence in the Asia Pacific and
Africa provides larger customer base for players in the rabies
treatment market.
This research report analyzes
this market on the basis of its market segments, major geographies,
and current market trends. This report provides comprehensive
analysis of
Market growth drivers
Factors limiting market
growth
Current market trends
Market structure
Market projections for
upcoming years
This report is a complete study
of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It
includes analysis of recent developments in technology, Porter’s
five force model analysis and detailed profiles of top industry
players. The report also includes a review of micro and macro factors
essential for the existing market players and new entrants along with
detailed value chain analysis.
Reasons for Buying this
Report
This report provides
pin-point analysis for changing competitive dynamics
It provides a forward
looking perspective on different factors driving or restraining
market growth
It provides a six-year
forecast assessed on the basis of how the market is predicted to grow
It helps in understanding
the key product segments and their future
It provides pin point
analysis of changing competition dynamics and keeps you ahead of
competitors
It helps in making informed
business decisions by having complete insights of market and by
making in-depth analysis of market segments
It provides distinctive
graphics and exemplified SWOT analysis of major market segments
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment